- Home
- TFSL vs AXSM Comparison
TFSL vs AXSM Comparison
Compare TFSL & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFSL
- AXSM
- Stock Information
- Founded
- TFSL 1938
- AXSM 2012
- Country
- TFSL United States
- AXSM United States
- Employees
- TFSL N/A
- AXSM N/A
- Industry
- TFSL Savings Institutions
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- TFSL Finance
- AXSM Health Care
- Exchange
- TFSL Nasdaq
- AXSM Nasdaq
- Market Cap
- TFSL N/A
- AXSM 4.2B
- IPO Year
- TFSL 2007
- AXSM 2015
- Fundamental
- Price
- TFSL $12.50
- AXSM $84.60
- Analyst Decision
- TFSL Hold
- AXSM Strong Buy
- Analyst Count
- TFSL 3
- AXSM 14
- Target Price
- TFSL $14.33
- AXSM $125.54
- AVG Volume (30 Days)
- TFSL 275.1K
- AXSM 893.5K
- Earning Date
- TFSL 01-28-2025
- AXSM 02-18-2025
- Dividend Yield
- TFSL 9.09%
- AXSM N/A
- EPS Growth
- TFSL 7.69
- AXSM N/A
- EPS
- TFSL 0.28
- AXSM N/A
- Revenue
- TFSL $304,660,000.00
- AXSM $338,457,000.00
- Revenue This Year
- TFSL N/A
- AXSM $44.77
- Revenue Next Year
- TFSL $7.19
- AXSM $67.70
- P/E Ratio
- TFSL $44.64
- AXSM N/A
- Revenue Growth
- TFSL N/A
- AXSM 51.47
- 52 Week Low
- TFSL $11.70
- AXSM $64.11
- 52 Week High
- TFSL $15.00
- AXSM $105.00
- Technical
- Relative Strength Index (RSI)
- TFSL 41.09
- AXSM 43.66
- Support Level
- TFSL $12.06
- AXSM $79.19
- Resistance Level
- TFSL $12.75
- AXSM $87.53
- Average True Range (ATR)
- TFSL 0.23
- AXSM 4.37
- MACD
- TFSL -0.00
- AXSM -0.02
- Stochastic Oscillator
- TFSL 60.27
- AXSM 61.27
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.